Latigo Biotherapeutics, Inc. (LTGO)
12.50
-0.51
(-3.92%)
USD |
NASDAQ |
Nov 06, 10:08
Latigo Biotherapeutics Shareholders Equity (Quarterly) : 12.50M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.50M |
| Date | Value |
|---|---|
| March 31, 2026 | 36.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Turn Therapeutics, Inc. | 0.6869M |
| Journey Medical Corp. | 32.11M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 833.74M |
| Veru, Inc. | 28.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.76M |
| Total Liabilities (Quarterly) | 52.26M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 1.148 |